Obamacare Question: Ditch Employer Mandate?

A left-leaning think tank whose research is often taken seriously by backers of the health-care overhaul has published a paper suggesting the administration should scrap the health law's requirement that employers offer coverage or pay a penalty.
Published Online: May 12, 2014

A left-leaning think tank whose research is often taken seriously by backers of the health-care overhaul has published a paper suggesting the administration should scrap the health law’s requirement that employers offer coverage or pay a penalty.

Why Don’t We Just Get Rid of the Employer Mandate?”, by three researchers at the Urban Institute, argues that the requirement won’t lead to many more people gaining coverage, since most firms that don’t currently offer benefits to all their workers will opt for the penalty, and most firms that already voluntarily offer benefits will want to carry on doing so.

The researchers say that the penalty isn’t necessary to stop employers from dumping their workers now that they can get coverage other ways. They reason that workers will still consider employer insurance attractive, and so employers will conclude that it’s worth providing because tax breaks on employee benefits offset some of the cost of providing them.

Read the full story here: http://on.wsj.com/1nEQHRe

Source: The Wall Street Journal



Feature
Recommended Articles
The UK government has come up with an innovative plan to increase public awareness of the increasing price of prescription drugs and what it costs the healthcare system
New delivery models related to the recent healthcare reform legislation may help drive up utilization, as discussed by Francois de Brantes, MS, MBA; Ateev Mehrotra, MD, MPH; and Arthur Vercillo, MD, FACS, in this seventh segment of the Healthcare Reform Stakeholders Summit, Spring 2015 series. They theorize that healthcare convenience and availability may actually lead to a loss in coordination of care.
In this seventh segment of the Healthcare Reform Stakeholders Summit, Spring 2015 series, Francois de Brantes, MS, MBA, and Arthur Vercillo, MD, FACS, discussed a number of issues related to pricing transparency, including access to information, decreased pricing variability, and antitrust concerns.
During this one-on-one interview, a part of the Oncology Stakeholders Summit, Spring 2015 series, Michael Kolodziej, MD, discusses payer considerations regarding coverage for new cancer treatments such as immuno-oncology therapies.
A study published in Health Affairs has found that primary care physicians refer women Medicaid enrollees to fewer preventive services than do their counterparts with private insurance coverage.